AstraZeneca PLCAZN:LSE

3,794.5
36.00 / 0.96%
878.82k
15.07%
0.3453
Latest price in GBXToday's changeShares traded1 year changeBeta
As of Apr 17 2014 13:39 BST.Data delayed by at least 15 minutes.

Search 538 articles on AstraZeneca PLC

UK cancer charity and companies test new style of drug trial
Boris Johnson launches MedCity to boost UK life sciences
Leading companies in patent reform fight
Big pharma's rise in China not held back by scandals
Drugmakers learn to blend commerce with philanthropy in Africa
Big pharma balks at investment in TB
Nice to rethink valuations of drugs for NHS
Manufacturers demand co-ordinated European energy policy
AstraZeneca slips as drug hopes knocked
Aerospace and automotive are UK's star performers

Reuters News Service company announcements are delayed by up to one hour.

© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.